Shanghai Pharmaceuticals Holding(601607.SH): Nicorandil tablets pass consistency evaluation.

date
18/09/2025
avatar
GMT Eight
Shanghai Pharmaceuticals (601607.SH) announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. (referred to as "Shandong Xinyi"...
Shanghai Pharmaceuticals Holding announced that its subsidiary Shandong Xinyi Pharmaceutical Co., Ltd. ("Shandong Xinyi") received the "Notification of Approval for Drug Supplementary Application" issued by the National Medical Products Administration. The drug, Nicardipine Tablets, has passed the generic drug quality and efficacy consistency evaluation. Nicardipine tablets are used for the treatment of angina.